Sarah Goodwin

Kathi Ovnic
Holly Korschun
September 1, 1998


Persons with EARLY PARKINSON'S disease are being recruited for four studies of new antiparkinsonian medications being conducted by neurologists in the Movement Disorders Program at Emory.

Qualified volunteers should be between 30 to 75 years of age. They should be in the early stages of Parkinson's disease, meaning they should have been diagnosed with Parkinson's disease or begun to exhibit symptoms within the past two years. Volunteers should not have received treatment, though for some of the studies, prior use of test doses of levodopa (L-dopa; Sinemet) is acceptable.

Persons with ESTABLISHED PARKINSON'S disease who are experiencing a deterioration in their response to levodopa are being recruited for another neurology study that will test a new formulation of the drug Zydis (Zydis Selegiline; selegiline/deprenyl). Persons with Parkinson's disease may also volunteer who are taking the following dopamine agonists: Parlodel, Permax, Mirapex or Requip.

Medical exams, tests and medications related to all the studies will be provided at no cost. Volunteers will be asked to visit The Emory Clinic, 1365 Clifton Rd., N.E., Atlanta, or Wesley Woods Health Center, 1841 Clifton Rd., N.E., Atlanta, once or twice a month for the duration of the study (duration varies per study).

For information, call Carol Ingram, R.N., at 404/728-6859.

- ### -

For more general information on The Robert W. Woodruff Health Sciences Center, call Health Sciences Communication's Office at 404-727-5686, or send e-mail to

Copyright ©Emory University, 1998. All Rights Reserved.